Avance Solo Negative Pressure Wound Therapy (NPWT) System
K-Number: K203369 · 2021-07-01
Device Summary
Frequently Asked Questions
What is the Avance Solo Negative Pressure Wound Therapy (NPWT) System?
Avance Solo Negative Pressure Wound Therapy (NPWT) System is a medical device that received FDA 510(k) clearance on 2021-07-01. The listed applicant is Molnlycke Health Care Us, LLC. The 510(k) number is K203369.
When did Avance Solo Negative Pressure Wound Therapy (NPWT) System receive FDA 510(k) clearance?
Avance Solo Negative Pressure Wound Therapy (NPWT) System received FDA 510(k) clearance on 2021-07-01, under 510(k) number K203369.
Who is the listed applicant for Avance Solo Negative Pressure Wound Therapy (NPWT) System?
The FDA 510(k) record lists Molnlycke Health Care Us, LLC as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Avance Solo Negative Pressure Wound Therapy (NPWT) System?
The FDA product code for Avance Solo Negative Pressure Wound Therapy (NPWT) System is OMP.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Molnlycke Health Care Us, LLC as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: OMP)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.